Our news

MITEM PHARMA ACQUIRES FLISINT®

Press Release, 4th of February 2025

MITEM PHARMA acquires FLISINT® from SANOFI

MITEM PHARMA ACQUIRES WORLDWIDE RIGHTS TO DESFERAL®

Press Release, 25th of September 2024

MITEM PHARMA acquires worldwide rights to DESFERAL® (deferoxamine) with the backing of TECHLIFE CAPITAL and MACSF.